» Authors » Bicheng Liu

Bicheng Liu

Explore the profile of Bicheng Liu including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 74
Citations 2270
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Gan Y, Nie S, Pang M, Huang R, Xu H, Liu B, et al.
Clin Kidney J . 2024 Aug; 17(8):sfae137. PMID: 39131078
Background: Electrolyte abnormalities are common symptoms of chronic kidney disease (CKD), but previous studies have mainly focussed on serum potassium and sodium levels. Chloride is an important biomarker for the...
12.
Luo S, Zheng X, Bao W, Nie S, Ding Y, Yue T, et al.
Signal Transduct Target Ther . 2024 Jun; 9(1):154. PMID: 38844816
Early insulin therapy is capable to achieve glycemic control and restore β-cell function in newly diagnosed type 2 diabetes (T2D), but its effect on cardiovascular outcomes in these patients remains...
13.
Wang C, Zhang Y, Shen A, Tang T, Li N, Xu C, et al.
Front Immunol . 2024 May; 15:1385696. PMID: 38770013
Background: Recent studies have demonstrated a strong association between acute kidney injury (AKI) and chronic kidney disease (CKD), while the unresolved inflammation is believed to be a driving force for...
14.
Yang B, Yang Y, Liu B, Yang M
Front Nutr . 2024 May; 11:1349876. PMID: 38699544
Malnutrition persists as one of the most severe symptoms in patients with chronic kidney disease (CKD) globally. It is a critical risk factor for cardiovascular and all-cause mortality in patients...
15.
Liu S, Wan H, Nie S, Cao H, Liu L, Liang H, et al.
J Clin Endocrinol Metab . 2024 Apr; 110(3):e650-e659. PMID: 38652239
Background: Hypoglycemic pharmacotherapy interventions for alleviating the risk of dementia remain controversial, particularly regarding dipeptidyl peptidase 4 (DPP4) inhibitors vs metformin. Our objective was to investigate whether the initiation of...
16.
Deng F, Qiu Y, Zhang X, Guo N, Hu J, Yang W, et al.
Antib Ther . 2024 Feb; 7(1):77-87. PMID: 38371956
Atopic dermatitis (AD) is a chronic inflammatory skin condition characterized by dysregulated immune responses. The key mediators of AD pathogenesis are T helper 2 (TH2) cells and TH2 cytokines. Targeting...
17.
Cheng Y, Nie S, Zhao X, Xu X, Xu H, Liu B, et al.
Nephrol Dial Transplant . 2024 Jan; 39(6):967-977. PMID: 38262746
Background: Postoperative acute kidney injury (AKI) is a common condition after surgery, however, the available data about nationwide epidemiology of postoperative AKI in China from large and high-quality studies are...
18.
Pi M, Nie S, Su L, Li Y, Cao Y, Gao P, et al.
Kidney Dis (Basel) . 2023 Dec; 9(6):517-528. PMID: 38089444
Introduction: Comprehensive data on the risk of hospital-acquired (HA) acute kidney injury (AKI) among adult users of opioid analgesics are lacking. This study aimed to systematically compare the risk of...
19.
Xu S, Ni H, Wu M, Xie X, Liu B, Zhang X, et al.
Clin Nephrol . 2023 Nov; 101(2):93-98. PMID: 38032142
A sporadic occurrence of Fanconi syndrome associated with adefovir dipivoxil (ADV) has been reported, particularly when confirmed by renal biopsy. This study presents the case of a 53-year-old man who...
20.
Zhang P, Jiang Y, Xu C, Zhou L, Zheng H, Xie D, et al.
EClinicalMedicine . 2023 Nov; 65:102273. PMID: 37954906
Background: Pegmolesatide, a synthetic peptide-based erythropoietin (EPO) receptor agonist, is being evaluated as an alternative to epoetin alfa for treating anemia of chronic kidney disease (CKD) in Chinese dialysis patients....